Minimal Residual Disease in Mouse Hepatocellular carcinoma [in vitro]
Residual tumor cells which remain dormant after MYC inactivation in a primary MYC-HCC derived cell line. Overall design: MYC-HCC clonal primary celll line treated with doxycyline for one week to inactivate the MYC oncogene. Viable cells used for scRNAseq.